228 related articles for article (PubMed ID: 17373573)
1. Inhibition of corneal neovascularization with endostatin delivered by adeno-associated viral (AAV) vector in a mouse corneal injury model.
Lai LJ; Xiao X; Wu JH
J Biomed Sci; 2007 May; 14(3):313-22. PubMed ID: 17373573
[TBL] [Abstract][Full Text] [Related]
2. Subconjunctival injection of recombinant AAV-angiostatin ameliorates alkali burn induced corneal angiogenesis.
Cheng HC; Yeh SI; Tsao YP; Kuo PC
Mol Vis; 2007 Dec; 13():2344-52. PubMed ID: 18199977
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of corneal neovascularization with plasmid pigment epithelium-derived factor (p-PEDF) delivered by synthetic amphiphile INTeraction-18 (SAINT-18) vector in an experimental model of rat corneal angiogenesis.
Kuo CN; Yang LC; Yang CT; Lai CH; Chen MF; Chen CY; Chen CH; Wu PC; Kou HK; Chen YJ; Hung CH; Tsai CB
Exp Eye Res; 2009 Nov; 89(5):678-85. PubMed ID: 19596319
[TBL] [Abstract][Full Text] [Related]
4. Adeno-associated virus-mediated antiangiogenic gene therapy with thrombospondin-1 type 1 repeats and endostatin.
Zhang X; Xu J; Lawler J; Terwilliger E; Parangi S
Clin Cancer Res; 2007 Jul; 13(13):3968-76. PubMed ID: 17606731
[TBL] [Abstract][Full Text] [Related]
5. Inducible adeno-associated virus vector-delivered transgene expression in corneal endothelium.
Tsai ML; Chen SL; Chou PI; Wen LY; Tsai RJ; Tsao YP
Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):751-7. PubMed ID: 11867594
[TBL] [Abstract][Full Text] [Related]
6. Experimental inhibition of corneal neovascularization by endostatin gene transfection in vivo.
Zhang P; Wu D; Ge J; Zhu Z; Feng G; Yue T; Lin J; Zheng H
Chin Med J (Engl); 2003 Dec; 116(12):1869-74. PubMed ID: 14687476
[TBL] [Abstract][Full Text] [Related]
7. [Human endostatin antiangiogenic gene therapy mediated by recombinant adeno-associated virus vector in nude mouse with endometriosis].
Sun JJ; Yin LR; Mi RR; Ma HD; Guo SJ; Shi Y; Gu YJ
Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):45-50. PubMed ID: 20367926
[TBL] [Abstract][Full Text] [Related]
8. Potent antitumour activity of the combination of HSV-TK and endostatin armed oncolytic adeno-associated virus for bladder cancer in vitro and in vivo.
Pan JG; Zhou X; Zeng GW; Han RF
J Surg Oncol; 2012 Mar; 105(3):249-57. PubMed ID: 21953122
[TBL] [Abstract][Full Text] [Related]
9. Adeno-associated virus-mediated gene transfer of endostatin inhibits angiogenesis and tumor growth in vivo.
Shi W; Teschendorf C; Muzyczka N; Siemann DW
Cancer Gene Ther; 2002 Jun; 9(6):513-21. PubMed ID: 12032662
[TBL] [Abstract][Full Text] [Related]
10. [Gene therapy of bladder cancer by using recombinant adeno-associated virus-endostatin: experiments in vitro and in vivo].
Lu BX; Han RF; Tang Y; Han YZ; Li SZ
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):802-5. PubMed ID: 17565858
[TBL] [Abstract][Full Text] [Related]
11. [Antisense vascular endothelial growth factor suppressed corneal neovascularization in rats].
Zhou LH; Xing YQ; Chen CL; Wang DW
Zhonghua Yan Ke Za Zhi; 2006 May; 42(5):426-30. PubMed ID: 16762237
[TBL] [Abstract][Full Text] [Related]
12. Recombinant adeno-associated virus 2-mediated antiangiogenic prevention in a mouse model of intraperitoneal ovarian cancer.
Isayeva T; Ren C; Ponnazhagan S
Clin Cancer Res; 2005 Feb; 11(3):1342-7. PubMed ID: 15709207
[TBL] [Abstract][Full Text] [Related]
13. [Research of the anti-tumor effect of human endostatin mediated by recombinant adeno-associated virus].
Lu GQ; Zha YY; Wu XB; Yang JG; Zhang XY; Fu M; Liang X; Wu M; Lin C
Ai Zheng; 2002 Dec; 21(12):1314-8. PubMed ID: 12520738
[TBL] [Abstract][Full Text] [Related]
14. [Intravesical perfusion of recombinant adeno-associated virus-endostatin in treatment of bladder cancer: experiments with mice].
Lu BX; Han RF; Tang Y; Lei MD; Li SZ
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(44):3157-8. PubMed ID: 19159603
[TBL] [Abstract][Full Text] [Related]
15. [Adeno-associated virus-mediated expression of human endostatin and its biological activity in vitro].
Li XH; Li XP; Li G; Liu X
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):651-4. PubMed ID: 15958300
[TBL] [Abstract][Full Text] [Related]
16. Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy.
Lai YK; Shen WY; Brankov M; Lai CM; Constable IJ; Rakoczy PE
Gene Ther; 2002 Jun; 9(12):804-13. PubMed ID: 12040462
[TBL] [Abstract][Full Text] [Related]
17. Intratumoral gene therapy of malignant brain tumor in a rat model with angiostatin delivered by adeno-associated viral (AAV) vector.
Ma HI; Lin SZ; Chiang YH; Li J; Chen SL; Tsao YP; Xiao X
Gene Ther; 2002 Jan; 9(1):2-11. PubMed ID: 11850717
[TBL] [Abstract][Full Text] [Related]
18. [Effects of double targeting gene therapy by suicide gene combined with endostatin gene in treatment of bladder cancer: an experimental study].
Pan JG; Zhou X; Han RF
Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(38):2700-4. PubMed ID: 19080691
[TBL] [Abstract][Full Text] [Related]
19. Endostatin gene therapy delivered by Salmonella choleraesuis in murine tumor models.
Lee CH; Wu CL; Shiau AL
J Gene Med; 2004 Dec; 6(12):1382-93. PubMed ID: 15468191
[TBL] [Abstract][Full Text] [Related]
20. Administration-route and gender-independent long-term therapeutic correction of phenylketonuria (PKU) in a mouse model by recombinant adeno-associated virus 8 pseudotyped vector-mediated gene transfer.
Ding Z; Georgiev P; Thöny B
Gene Ther; 2006 Apr; 13(7):587-93. PubMed ID: 16319947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]